AberActives

What AberActives does

AberActives is a French marine biotechnology company founded in December 2021 as a spin-off of the Station Biologique de Roscoff (CNRS – Sorbonne Université), a globally recognized institute for fundamental algal research. Headquartered at the Blue Valley® Innovation Park in Roscoff, Brittany, the company operates an R&D laboratory on the grounds of the Roscoff Biological Station. With a team of approximately 12 staff led by CEO Denis Drouin, General Manager and co-founder Robert Larocque, and Scientific Board Chairman Gurvan Michel, AberActives develops enzymatic processes for extracting bioactive compounds — primarily fucan oligosaccharides — from brown algae (seaweed). The extracted ingredients are positioned for use in cosmetics and nutraceuticals applications, with claimed functional properties spanning cell regeneration, hydration, anti-aging, immunomodulation, and dermal health.

The company's core technology is a biorefinery approach based on enzymatic hydrolysis using patented bacterial enzymes that are not commercially available elsewhere. These enzymes enable the extraction of sulfated fucan oligosaccharides from brown algae that conventional chemical extraction methods cannot produce at scale. The process is positioned as more ecologically responsible than traditional chemical extraction because it avoids organic solvents and is non-energy-intensive. AberActives' competitive positioning rests on three pillars: proprietary patented enzymatic IP, founders and R&D leadership who are alumni of the Roscoff Biological Station, and physical proximity to the Brittany coastline, which hosts over 800 marine species and is one of France's largest seaweed deposit zones.

AberActives remains in pre-commercial, pre-industrialization phase. Its business model targets B2B sales of marine-derived bioactive ingredients to cosmetics and nutraceuticals manufacturers, primarily in Europe, with go-to-market executed through direct technical engagement and participation in industry trade shows such as Cosmetic 360°, Cosm'ing, Bio2Actives, and Blue Cluster Forum. To date, the company has been financed predominantly through non-dilutive grants and awards, including the Emergys Bretagne regional prize (August 2022), the Fondation Grand Ouest "Coup de cœur recherche" prize (September 2022), and the French Tech Emergence Bursary from BPI France (December 2022). In 2024–2025 the company received the i-Lab 2024 laureate designation under France 2030 and Index Blue Tech 2024 recognition. As of March 2025, AberActives is raising €1 million to fund pre-industrialization and its first small-scale production runs. No commercial revenue has been disclosed.

Name

AberActives

Legal name

AberActives

Website

https://aberactives.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

AberActives is a French marine biotechnology spin-off of the Roscoff Biological Station that uses patented bacterial enzymes to extract bioactive fucan oligosaccharides from brown algae for cosmetics and nutraceuticals manufacturers. Founded in 2021, the company is pre-revenue and raising €1M for pre-industrialization.

Ownership category

akta.pro rank

Product category

Marine bioactive ingredients

NAICS

Chemical Manufacturing (325)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Seaweed Hydrocolloids (Agar, Carrageenan, Alginates) (AFAJAMAD)

akta.pro secondary industry

Biological Formulation, Fermentation & Scale-Up Manufacturing (AFABAEAM)

Keywords

• Marine biotechnology
• Algal bioactive ingredients
• Enzymatic extraction
• Fucan oligosaccharides
• Cosmeceutical ingredients

Headquarters

HQ city

Roscoff

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Marine ingredient sales: AberActives generates revenue through the sale of marine-based bioactive ingredients derived from seaweed. The company extracts biomolecules (oligosaccharides, sulfated fucans) targeting the cosmetics and nutraceuticals markets. These ingredients contribute to cell regeneration, wound healing, hydration, and dermal health. The company is currently in pre-industrialization phase seeking €1 million to launch first small-scale production.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

AberActives develops and sells marine-derived bioactive ingredients (oligosaccharides, sulfated fucans) extracted from brown algae using patented bacterial enzymes through an enzymatic hydrolysis biorefinery process. The ingredients are supplied to cosmetics and nutraceuticals manufacturers for use in anti-aging, moisturizing, regenerative, immunomodulating, and skin-health formulations. The company is currently in pre-industrialization phase and is raising €1 million to launch its first small-scale production.

Product overview

AberActives offers a single core product line consisting of marine algal extracts derived from seaweed biomass. The company uses patented enzymatic hydrolysis processes to extract biomolecules from brown algae (particularly laminaria/kelp). The extraction technique is positioned as more precise, ecologically responsible, and cost-effective compared to traditional chemical methods. The company is in early R&D phase (founded December 2021) and is seeking funding to launch pre-industrial production. Target markets are cosmetics and nutraceuticals industries.

Differentiator

Problem solved

Functional benefit

Products and services

• Marine Algal Extracts Natural bioactive extracts derived from brown algae (laminaria/kelp) using proprietary enzymatic hydrolysis with patented bacterial enzymes. The extracts deliver bioactivities including cell regeneration, wound healing, hydration, antioxidant, anti-infectious, and immune-boosting properties, targeting cosmetics formulators (anti-aging, moisturizing, protective, regenerating skin care) and nutraceutical manufacturers (functional health supplements).

Quantifiable outcome

• More precise, ecological, and cost-effective extraction compared to conventional chemical methods

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Nine partnerships are on record, tiered core and supporting.

• Station Biologique de Roscoff (CNRS – Sorbonne Université)coreStrategic or Co-development PartnerAberActives is a spin-off/division of the Roscoff Biological Station. The company operates in facilities rented from this world-leading algal research institute. The founders are all alumni of this prestigious institution, providing deep scientific expertise and access to research infrastructure. This partnership provides unparalleled expertise in seaweed biotechnology and access to extensive marine biodiversity.
• Blue Valley® Innovation ParkcoreStrategic or Co-development PartnerAberActives is located in the Laber building within the Blue Valley® Science Park, a facility operated by Haut-Léon Communauté. The park provides a brand-new R&D laboratory fully equipped for technology transfer and offers an ecosystem conducive to marine biotechnology innovation.
• Cosmetic ValleysupportingStrategic or Co-development PartnerNational competitiveness cluster for cosmetics. AberActives participates in Cosmetic Valley events and exhibitions, providing access to the cosmetics industry ecosystem and networking opportunities with manufacturers and industry partners.
• Pôle Mer Bretagne AtlantiquesupportingStrategic or Co-development PartnerBlue Cluster maritime competitiveness pole. AberActives participates in Blue Cluster Forum events dedicated to macro- and micro-algae applications, connecting with stakeholders in blue biotechnology and sustainable food industry.
• SATT Ouest ValorisationsupportingTechnology or IntegrationTechnology transfer organization for Western France. Supports the transfer of research innovations from academic institutions to commercial applications, likely involved in the commercialization of CNRS research.
• Tech Brest-IroisesupportingStrategic or Co-development PartnerTechnopole organization supporting innovative companies in the Brest area. AberActives participates in Technopole events including Young Start-ups Forum.
• Biotech & Santé BretagnesupportingStrategic or Co-development PartnerRegional biotechnology and health cluster bringing together companies and research institutions in Brittany's biotech sector.
• Le Village by CA FinistèresupportingStrategic or Co-development PartnerAgricultural bank's startup incubation village providing support and networking for innovative companies in Finistère.
• Emergys BretagnesupportingStrategic or Co-development PartnerRegional incubator for innovative deep tech companies. AberActives received Emergys prize and financial assistance to cover strategic creation costs.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Marinova: Australian marine biotechnology company specializing in fucoidan (sulfated fucan) extraction from brown seaweed for nutraceuticals and cosmetics. Direct overlap with AberActives on the core molecule class (fucans) and end markets.
• Gelyma: French marine biotech company producing bioactive extracts from microalgae and macroalgae for cosmetics and nutraceuticals. Closest comparable in size, geography, and end-market focus.

Broad incumbents

• Olmix Group: Established Breton marine biotechnology company extracting value from algae across animal care, plant care, and human nutrition. Same geographic ecosystem and algae-feedstock category as AberActives, but with a much broader product portfolio.
• SEPPIC (Air Liquide Healthcare Specialty Ingredients): French specialty ingredient supplier serving cosmetics and nutrition with biotechnologically-derived actives. Represents a potential acquirer or competitor with established European B2B channels.
• Corbion (Algae Ingredients / TerraVia legacy): Global ingredients company with algae-based specialty ingredient capabilities inherited from TerraVia/Solazyme. Large-scale fermentation platform competing for the same algae-ingredient opportunity.
• Cargill (SeaMore / algae initiatives): Global ingredient giant with seaweed and algae-derived hydrocolloid programs. Represents the largest-scale competitive threat via capital, distribution, and customer reach in nutraceuticals.
• Lessonia: French manufacturer of algae- and plant-based cosmetic ingredients supplying B2B formulators. Operates in the same Breton/French algae ecosystem and serves overlapping cosmetics customers.
• Algaia: French seaweed-extract company producing alginates, fucoidans, and other algae-derived ingredients for food, feed, and personal care. Directly comparable ingredient portfolio and European B2B customer base.
• Solabia Group: French specialty ingredient producer with biotechnology-derived bioactive ingredients for cosmetics and nutrition. Comparable B2B ingredient model and shared European customer base.

Emerging players

• Cyanotech: US-based microalgae producer of spirulina and astaxanthin for nutrition markets. Comparable algae-derived bioactives business model targeting nutraceuticals.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/aberactives-sas

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AberActives